Laurion Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.64M | Buy |
+18,900
| New | +$1.81M | 0.07% | 224 |
|
|
2025
Q1 | – | Sell |
-91,374
| Closed | -$8.18M | – | 341 |
|
|
2024
Q4 | $7.3M | Buy |
91,374
+17,971
| +24% | +$1.56M | 0.13% | 116 |
|
|
2024
Q3 | $6.61M | Buy |
73,403
+66,976
| +1,042% | +$5.63M | 0.09% | 99 |
|
|
2024
Q2 | $506K | Buy |
+6,427
| New | +$527K | 0.01% | 358 |
|
|
2024
Q1 | – | Sell |
-125,317
| Closed | -$10.3M | – | 587 |
|
|
2023
Q4 | $10.3M | Buy |
+125,317
| New | +$9.55M | 0.09% | 182 |
|
|
2023
Q3 | – | Sell |
-8,674
| Closed | -$764K | – | 595 |
|
|
2023
Q2 | $764K | Buy |
+8,674
| New | +$747K | ﹤0.01% | 393 |
|
|
2022
Q4 | – | Sell |
-48,253
| Closed | -$3.91M | – | 500 |
|
|
2022
Q3 | $3.9M | Buy |
+48,253
| New | +$4.34M | 0.02% | 273 |
|
|
2022
Q2 | – | Sell |
-4,481
| Closed | -$454K | – | 613 |
|
|
2022
Q1 | $497K | Buy |
+4,481
| New | +$473K | 0.01% | 319 |
|
|
2021
Q4 | – | Sell |
-37,120
| Closed | -$4.65M | – | 663 |
|
|
2021
Q3 | $4.65M | Buy |
37,120
+27,628
| +291% | +$3.58M | 0.02% | 350 |
|
|
2021
Q2 | $1.18M | Sell |
9,492
-26,637
| -74% | -$3.34M | 0.01% | 419 |
|
|
2021
Q1 | $4.27M | Sell |
36,129
-10,131
| -22% | -$1.19M | 0.02% | 348 |
|
|
2020
Q4 | $5.42M | Sell |
46,260
-80,674
| -64% | -$8.88M | 0.04% | 236 |
|
|
2020
Q3 | $13.2M | Buy |
126,934
+52,947
| +72% | +$5.32M | 0.16% | 137 |
|
|
2020
Q2 | $6.79M | Buy |
+73,987
| New | +$7.09M | 0.08% | 200 |
|
|
2019
Q1 | – | Sell |
-79,647
| Closed | -$7.25M | – | 1117 |
|
|
2018
Q4 | $7.25M | Buy |
+79,647
| New | +$7.44M | 0.13% | 215 |
|
|
2018
Q3 | – | Sell |
-5,377
| Closed | -$460K | – | 1399 |
|
|
2018
Q2 | $460K | Buy |
+5,377
| New | +$449K | ﹤0.01% | 984 |
|
|
2017
Q3 | – | Sell |
-6,000
| Closed | -$533K | – | 1766 |
|
|
2017
Q2 | $533K | Buy |
+6,000
| New | +$506K | ﹤0.01% | 1234 |
|
|
2017
Q1 | – | Sell |
-2,800
| Closed | -$219K | – | 1464 |
|
|
2016
Q4 | $199K | Buy |
+2,800
| New | +$220K | ﹤0.01% | 1013 |
|
|
2015
Q1 | – | Sell |
-55,729
| Closed | -$4.02M | – | 415 |
|
|
2014
Q4 | $4.02M | Buy |
+55,729
| New | +$3.87M | 0.09% | 102 |
|
|
2014
Q2 | – | Sell |
-600
| Closed | -$37K | – | 319 |
|
|
2014
Q1 | $37K | Sell |
600
-11,891
| -95% | -$693K | ﹤0.01% | 228 |
|
|
2013
Q4 | $717K | Buy |
+12,491
| New | +$708K | 0.02% | 138 |
|
Other funds holding MDT
VCM
VPM
Laurion Capital Management's MDT Position: Q1 2026 in Review
Laurion Capital Management opened a new position in Medtronic (MDT) in Q1 2026: 18,900 shares worth $1.64M. The stake represents 0.07% of the portfolio and ranks #224 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in MDT as recently as Q4 2024.
Laurion Capital Management first reported a position in MDT in Q4 2013 and has held it in 21 quarters since. The position peaked at $13.2M in Q3 2020. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Laurion Capital Management held 18,900 shares of Medtronic worth $1.64M as of Q1 2026.
- Medtronic was a new Laurion Capital Management position in Q1 2026.
- Medtronic made up 0.07% of Laurion Capital Management's portfolio in Q1 2026, its #224 holding.
- Laurion Capital Management first reported a position in Medtronic in Q4 2013 and has held it in 21 quarters since.
- Laurion Capital Management's Medtronic position peaked at $13.2M in Q3 2020.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.